Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
276studies shown
Showing 1-12 of 276
Behavioral study icon
RecruitingNCT05965622

(Cost)-Effectiveness of ABFT for Suicidal Youth.

This summary needs review. Please check the official study record and contact the research team for details.

In Belgium
SuicidalityBehavioralFrom 18 Years to 25 Years
Countries
Belgium, Netherlands
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Condition
Suicidality
Drug study icon
RecruitingNCT07219953

Brenipatide in people with Addiction

This study is recruiting in the United States, in the United Kingdom, in Belgium, .... It is testing brenipatide for Addiction.

In Belgium
AddictionDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States, United Kingdom, Belgium, ...
Sponsor
Eli Lilly and Company
Condition
Addiction
Drug study icon
RecruitingNCT07219966

Brenipatide in people with Moderate-to-Severe Addiction

This study is recruiting in the United States, in the United Kingdom, in Belgium, .... It is testing brenipatide for Addiction.

In Belgium
AddictionDrugFrom 18 Years to 75 Years
Countries
United States, United Kingdom, Belgium, ...
Sponsor
Eli Lilly and Company
Condition
Addiction
Drug study icon
RecruitingNCT06126224

KarXT for Schizophrenia

This study is recruiting in the United States, in Canada, in the United Kingdom, .... It is testing KarXT for Schizophrenia.

In Belgium
SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT06585787

KarXT for Schizophrenia

This study is recruiting in the United States, in France, in Belgium, .... It is testing KarXT for Schizophrenia.

In Belgium
SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, France, Belgium, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Device study icon
RecruitingNCT07115628

Accelerated TMS for Treatment-Resistant ECT

This study is looking at whether Transcranial Magnetic Stimulation can help people with depression. Participants take part in Transcranial Magnetic Stimulation and complete follow-up assessments.

In Belgium
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 70 Years
Countries
Belgium
Sponsor
Universitair Ziekenhuis Brussel
Condition
Depression
Device study icon
RecruitingNCT05923801

Changing Tactics? Optimizing ECT in Difficult-to-treat Depression

This study is looking at care and outcomes for people with Depression. Taking part may give some people access to switch to BT electrode position, but direct benefit is not guaranteed.

In Belgium
DepressionDeviceOver 18 Years
Countries
Belgium
Sponsor
Universitaire Ziekenhuizen KU Leuven
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.